Clinical trial
Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients
NCT06096064 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients
- Lead sponsor
- Methodist Health System
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2022
- Completion date
- August 21, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
unfractionated heparin